Post-traumatic stress disorder

• 1. Introduction

  ›

  Post-traumatic stress disorder sits at the intersection of memory, fear, and survival. Most people who live through something terrible do not develop it. But for those who do, the traumatic event does not stay in the past. It intrudes on the present through vivid flashbacks, nightmares reported in 50 to 70% of cases, and a hair-trigger alarm system that never fully resets. The term itself only entered formal use in the 1970s, driven largely by U.S. veterans returning from Vietnam. In 1980, the American Psychiatric Association gave it an official name in the third edition of the Diagnostic and Statistical Manual of Mental Disorders. Yet the condition it describes reaches back far further than that. Ancient Assyrian soldiers, described in written sources from 1300 to 600 BCE, struggled to reconcile the violence of war with ordinary civilian life. How does a disorder so old remain so poorly understood? And why, after decades of research and treatment, do its roots in the brain, its boundaries across cultures, and its best remedies still spark genuine scientific disagreement?

• 2. Who Is at Risk

  ›

  Rape carries the highest single-event risk: 19% of those who experience it develop PTSD. Torture is close behind at 40% for those exposed. Sexual violence more broadly sits at 11.4%. These numbers from the source reveal something important: it is not simply the severity of a threat that predicts PTSD, but how personal, inescapable, and deliberate that threat is. Men are more likely to experience a traumatic event of any kind, yet women are more likely to develop PTSD. The reason is that women face a higher proportion of high-impact traumas, including interpersonal violence and sexual assault. Refugees illustrate the extremity of that exposure. PTSD rates within refugee populations range from 4% to 86%, a span so wide it reflects both the diversity of displacement experiences and the difficulty of measuring distress across cultures. Traffic accidents represent the most routine gateway to the disorder. Roughly 2.6% of adults who survive a non-life-threatening crash develop PTSD; that figure nearly doubles to 4.6% following a life-threatening accident. Unexpected bereavement is the most common traumatic event type reported in cross-national surveys, and while most people do not develop PTSD after it, it accounts for approximately 20% of PTSD cases worldwide simply because so many people experience it. About 22% of those exposed to combat develop PTSD, and in roughly 25% of military personnel who do develop it, the onset is delayed.

• 3. Inside the Traumatized Brain

  ›

  Vietnam War combat veterans with PTSD showed a 20% reduction in the volume of their hippocampus compared to veterans without such symptoms. That finding from a 2007 study captured in concentrated form what neuroimaging had been suggesting for years: PTSD physically reshapes the brain. The hippocampus normally places memories in the correct context of space and time. Under extreme stress, its activity is suppressed, and the experience is encoded incompletely. When a similar trigger later arises, the brain perceives the original event as happening again because the memory was never properly recorded. The amygdala drives this process. In PTSD, the amygdala's basolateral nucleus becomes hyperreactive, developing strong associations between neutral cues and fear. The central nucleus of the amygdala then fires the full fear response: elevated startle, behavioral threat reaction, and the physiological alarm that feels so physically real. The medial prefrontal cortex, which normally dampens this cycle during extinction, fails to exert sufficient control. Cortisol plays a counterintuitive role. Most people with PTSD show low cortisol secretion alongside high catecholamine levels. Because cortisol normally helps restore calm after a stress response, people with low levels experience a poorly contained and more distressing response that sets the stage for the disorder. A study of Swedish soldiers serving in Bosnia and Herzegovina found that those with low pre-service salivary cortisol levels had a higher risk of developing PTSD symptoms following war trauma. The immune system is also disrupted. Studies show elevated cytokine levels and reduced activity of microglia in the brain in response to immune challenges, which is associated with greater severity of anhedonic symptoms.

• 4. The Long Road to a Name

  ›

  Samuel Pepys wrote about intrusive and distressing symptoms following the 1666 Fire of London, one of the earliest documented accounts of what we now recognize as post-traumatic illness. Across the centuries, soldiers' experiences were filed under a rotating roster of labels: "railway spine", "soldier's heart", "shell shock", "war nerves", "battle fatigue", "combat neurosis". The DSM-I of 1952 included a related category called "gross stress reaction", defined as a normal personality responding to overwhelming fear. But it was the aftermath of Vietnam that forced the formal reckoning. The term "post-traumatic stress disorder" was first recommended in a working group finding presented to the Committee of Reactive Disorders in early 1978. When DSM-III published it as an official diagnosis in 1980, the diagnostic criteria were built largely around American combat veterans. That narrow origin had lasting consequences. In 1975, Ann Wolbert Burgess and Lynda Lytle Holmstrom had already seen the gap. They defined rape trauma syndrome to highlight the striking similarities between veterans returning from war and rape victims, pushing toward a broader understanding of what causes PTSD. By 1985, edited volumes such as The Trauma of War: Stress and Recovery in Viet Nam Veterans, edited by Stephen Sonnenberg and Arthur Blank, were structuring the field's emerging literature. The DSM-5, published in 2013, moved PTSD out of the anxiety disorders category and into a newly created grouping called "trauma and stressor-related disorders", recognizing that fear is not the only emotional core of the condition.

• 5. Treatment Landscape

  ›

  Prolonged exposure therapy, cognitive processing therapy, and eye movement desensitization and reprocessing are the three treatments backed by the strongest evidence. The U.S. Department of Veterans Affairs has actively trained mental health staff in the first two specifically to better serve veterans. EMDR has an unusual origin story. Francine Shapiro noticed that, when thinking about her own disturbing memories, her eyes moved rapidly. When she brought those eye movements under control, the memories became less distressing. In 2002, she and Maxfield published a theory called adaptive information processing to explain the mechanism. Meta-analyses comparing EMDR to cognitive behavioral therapy find the two approaches indistinguishable in overall effectiveness, though the contribution of the eye movement component specifically remains unclear. Among medications, four antidepressants have shown a small to modest benefit over placebo: sertraline, fluoxetine, paroxetine, and venlafaxine. Paroxetine and sertraline hold FDA approval for PTSD treatment. Benzodiazepines occupy a cautionary corner of the treatment literature. Evidence suggests they may actually increase the risk of developing PTSD by a factor of 2 to 5 when used in its immediate aftermath, and may worsen outcomes in people who already have the disorder. MDMA-assisted psychotherapy has generated significant attention. Fourteen systematic reviews suggest it may substantially improve symptoms compared to psychotherapy alone, but the FDA rejected it for PTSD treatment in 2024, citing trial design and safety concerns. Canada and Australia have both created limited pathways for authorized use. In 2025, the FDA granted breakthrough therapy designation for methylone as a potential PTSD treatment.

• 6. Culture, Diagnosis, and the Limits of a Western Lens

  ›

  Ethnopsychology studies in Nepal found that the local term piDaa may align with trauma and suffering, but people who suffer from piDaa are also considered paagal, meaning mad, and face negative social stigma. That single observation captures a broader problem: the PTSD diagnostic framework was built through the Euro-American paradigm of psychology and does not travel cleanly across cultural contexts. Designating the effects of trauma as an affliction of the spirit is common in many non-Western cultures. Idioms such as "soul loss" and "weak heart" express a preference to locate suffering in a spirit-body or heart-body relationship rather than a mind-body framework. These idioms also reflect how collectivist cultures tend to address trauma: through familial, cultural, and religious activities, not clinical diagnosis. When Sudanese refugees relocated to Uganda were studied, many were focused on material hardship rather than psychological distress, and few presented PTSD symptoms at all. Displaced people from Burundi showed symptoms of depression and anxiety, but only a few of the specific PTSD markers. Anthropologists have argued that for traumas extending beyond the individual, particularly the effects of war on entire communities, terms like "social suffering" or "cultural bereavement" may better describe what is happening than any single psychiatric diagnosis. The researchers from the Grady Trauma Project noted in 2012 that public attention had disproportionately focused on combat-related PTSD, obscuring the scale and nature of civilian PTSD, which encompasses traumas ranging from the September 11 attacks to Hurricane Katrina.

• 7. Scale and Ongoing Questions

  ›

  In the United States, about 3.5% of adults have PTSD in a given year, and 9% develop it at some point in their lives. Women are more than twice as likely as men to have it at some point, at 9.7% versus 3.6%. The U.S. Department of Veterans Affairs estimated that 830,000 Vietnam War veterans had symptoms of PTSD. For the 2.16 million U.S. troops deployed in combat zones between 2001 and 2010, the estimated two-year treatment costs for combat-related PTSD ran between $1.54 billion and $2.69 billion. Globally, rates during a given year are between 0.5% and 1% in much of the world outside the United States, rising significantly in regions of armed conflict. A pooled analysis found prevalence rates for complex PTSD of 4% in non-war-exposed, economically developed countries, climbing to 15% in war-exposed or less economically developed regions. Genetics accounts for approximately 30% of the variance in PTSD susceptibility. Research by neuroscientist Dr. Rachel Yehuda on Holocaust survivors and their offspring found measurable effects on methylation of the stress-linked FKBP5 gene both in parents who experienced trauma in concentration camps and in their children, suggesting psychological trauma can carry across generations. In 2020, the FDA granted marketing approval for an Apple Watch app called NightWare, which monitors heart rate and body movement to detect nightmares in progress and vibrates to interrupt them. It is a small tool, but it illustrates where the field stands: still improvising at the edges of a disorder that affects tens of millions of people worldwide, while the basic science of the hypothalamic-pituitary-adrenal axis, the amygdala, and the immune system continues to accumulate.